CARPENTER CHRISTOPHER L. (Chief Medical Officer) sold 57.9% of their position (48K shares) of RUBIUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $646.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2019ACC: 0001104659-19-073955
Officer· Chief Medical Officer
Since Jul 2018
-48K
Net shares
Net seller
$646.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
48K acquired · 96K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+48K
Price / share
$2.87
Trade value
$137.76K
% of position
137.8%
12/16/2019
34.84K→82.84K
Common Stock
Direct
Shares
−48K
Price / share
$13.48
Trade value
$646.90K
% of position
57.9%
12/16/2019
82.84K→34.84K
Total
Net shares
+0.00
Net value
-$509.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2019 | M · Option Exercise | +48K | $2.87 | $137.76K | 137.8% | 34.84K | 82.84K |
| Common Stock Direct | 12/16/2019 | S · Sale | −48K | $13.48 | $646.90K | 57.9% | 82.84K | 34.84K |
| Total | +0.00 | -$509.14K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
48K shares
Shares
−48K
Strike price
2.87
Held after
523.16K
Exercisable
—
12/16/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock48K shares | 12/16/2019 | M · Option Exercise | −48K | 2.87 | — | 523.16K |